Postdoctoral Scientists in New Immune Checkpoints and Immunotherapies, New York City, US in New York City, New York at Albert Einstein College of Medicine,

New postdoctoral scientist positions are open to work on our newly discovered immune checkpoint pathways including 1) basic studies in mechanisms; 2) translational immunotherapies in diseases. Our lab focuses on new immune checkpoint pathways and novel immunotherapies from fundamental discoveries to novel drugs to clinical trials. More information can be found in our lab website (https://www.xingxingzanglab.org) and some of our new publications (Nat Commun. 15:11, 2024; 13:2506, 2022; Sci Adv. 10:eadk1857, 2024; 8:eabm7012, 2022; Clin Cancer Res. 30:865, 2024; 27:2636, 2021; Cell Mol Immunol. 20:694, 2023; Dev Cell 58:2700, 2023; J Clin Invest. 132:e163620, 2022; Sci Immunol. 6:eabf9792, 2021).

The lab is well funded and has successfully mentored a total of 71 trainees so far. The pay scale is higher than NIH guidelines ($65,000 with adjustment for more senior candidates). We prefer candidates with at least one first author research publication in good scientific journals.

To apply:

Send a single PDF file to xingxing.zang@einsteinmed.edu

Professor XingXing Zang

Albert Einstein College of Medicine

1301 Morris Park Ave

Bronx NY 10461

Albert Einstein College of Medicine is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, protected veteran or disabled status, or genetic information. Einstein seeks candidates whose skills and personal and professional experience have prepared them to contribute to our campus and the communities we serve.